References
- Holdcroft A. Gender bias in research: how does it affect evidence based medicine? J R Soc Med 2007; 100(1): 2–3. doi: 10.1258/jrsm.1001.1.2.
- Liu KA, Dipietro Mager NA. Women's involvement in clinical trials: historical perspective and future implications. Pharmacy Practice 2016; 14(1): 708. doi: 10.18549/PharmPract.2016.01.708.
- Sundari Ravindran T, Teerawattananon Y, Tannenbaum C, Vijayasingham L. Making pharmaceutical research and regulation work for women. BMJ 2020; 371: m3808. doi: 10.1136/bmj.m3808.
- Mirin AA. Gender disparity in the funding of diseases by the U.S. National Institutes of Health. J Women's Health (Larchmt) 2021; 30(7): 956–963. doi: 10.1089/jwh.2020.8682.
- Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2021; 5(1): 51–54. doi: 10.1002/rth2.12468.
- Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4(6): 836–41. doi: 10.1046/j.1365-2516.1998.00208.x.
- Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351 (9101): 485–9. doi: 10.1016/S0140-6736(97)08248-2.
- Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5(1): 40–8. doi: 10.1046/j.1365-2516.1999.00285.x.
- Khair K, Holland M, Pollard D. The experience of girls and young women with inherited bleeding disorders. Haemophilia 2013; 19(5): e276–81. doi: 10.1111/hae.12155.
- Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022; 6: e12652. doi: 10.1002/rth2.12652.
- Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022; 28: 316–325. doi: 10.1111/hae.14514.
- Noone D, Skouw-Rasmussen N, Lavin M, van Galen KPM, Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium. Haemophilia 2019; 25(3): 468–474. doi: 10.1111/hae.13722.
- van Galen K, Lavin M, Skouw-Rasmussen N, et al. Clinical management of women with bleeding disorders: A survey among European haemophilia treatment centres. Haemophilia 2020; 26(4): 657–662. doi: 10.1111/hae.14043.
- Presky KO, Kadir RA. Women with inherited bleeding disorders – Challenges and strategies to improved care. Thromb Res 2020; 196: 569–578. doi: 10.1016/j.thromres.2019.07.004.
- Arya S, Wilton P, Page D, et al. “They don’t really take my bleeds seriously”: Barriers to care for women with inherited bleeding disorders. J Thromb Haemost 2021; 19(6): 1506–1514. doi: 10.1111/jth.15311.
- Byams VR, Miller CH, Bethea FM, et al. Bleeding disorders in women and girls: state of the science and CDC Collaborative Programs. J Women's Health 2022; 31(3): 301–309. doi: 10.1089/jwh.2022.0008.
- van Galen K, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19(8): 1883–1887. doi: 10.1111/jth.15397.
- van Galen K, Lavin M, Skouw-Rasmussen N, et al.; the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Bleeding Disorders (EAHAD). European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837–847. doi: 10.1111/hae.14379.